Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
741 to 760 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| U54CA210184 | Center on the Physics of Cancer Metabolism | 1 | 2020 |
| U54CA210190 | Center for Modeling Tumor Cell Migration Mechanics | 1 | 2020 |
| U54HD090216 | Kansas Intellectual and Developmental Disabilities Research Center | 1 | 2020 |
| UM1HG008898 | Genomic Architecture of Common Disease in Diverse Populations | 1 | 2020 |
| R01CA196205 | NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASIS | 7 | 2019 |
| R01DK056621 | Hepatic autophagy, Stem cells and Fibrosis | 6 | 2019 |
| R01EB007534 | Paracrine interactions during cardiac and endothelial co-differentiation of hPSCs | 3 | 2019 |
| K12CA132783 | Paul Calabresi Career Development Award for Clinical Oncology (K12) | 2 | 2019 |
| P01HL014985 | Adaptation to Hypoxia | 2 | 2019 |
| R01CA181746 | Harnessing beneficial off-target effects of kinase inhibitors in lung cancer | 2 | 2019 |
| R01CA192381 | Exploitation of RAS signaling to develop therapy and early detection strategies for PDA | 2 | 2019 |
| DP5OD021351 | Modulation of Bone Formation by SHN3 | 1 | 2019 |
| F31CA206341 | Investigating the Mechanisms of Resistance to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma | 1 | 2019 |
| F31HL142151 | Identification and functional characterization of regulatory genetic variation through interrogation and integration of multiple molecular phenotypes in a large collection of iPSCs and derived cells | 1 | 2019 |
| F32DK115109 | The role of DDR1 in podocyte lipotoxicity and progression of Alport Syndrome | 1 | 2019 |
| I01CX000114 | Molecular Mechanisms of Immune Therapy for Bone Marrow Failure | 1 | 2019 |
| K08CA193982 | The Interaction of Autophagy and BRAF Mutations in Brain Tumors | 1 | 2019 |
| K08HL127102 | Beta 1 Integrin in the Lung | 1 | 2019 |
| K99CA225633 | Determining structural features of a collagen lysyl hydroxylase that promotes lung cancer metastasis | 1 | 2019 |
| P20CA202924 | 1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=38